An estimated glomerular filtration rate (eGFR) is a useful estimate of kidney filtering, but one number rarely tells the whole story. This guide explains eGFR ranges, chronic kidney disease (CKD) stages, urine albumin results, temporary causes of change, and practical questions to take to a clinician. It is designed as a reference to revisit whenever laboratory results, medicines, or health circumstances change.
Overview
eGFR is calculated from a blood creatinine measurement and other information, such as age and sex, using a validated equation. It is reported in milliliters per minute per 1.73 square meters (mL/min/1.73 m²). Because creatinine can be affected by muscle mass, diet, hydration, and illness, eGFR is an estimate—not a direct measurement of every aspect of kidney health.
Doctors generally consider chronic kidney disease when a kidney abnormality persists for at least three months. The abnormality may be a persistently reduced eGFR, increased urine albumin, an abnormal urine sediment, structural changes on imaging, or another marker of kidney damage. A single low eGFR does not automatically establish CKD, particularly when the result was obtained during dehydration, infection, hospitalization, or another acute illness.
eGFR ranges and CKD categories
| eGFR category | eGFR range | General interpretation |
|---|---|---|
| G1 | 90 or higher | Normal or high; CKD requires another marker of kidney damage |
| G2 | 60–89 | Mildly decreased; CKD requires another marker of kidney damage |
| G3a | 45–59 | Mildly to moderately decreased |
| G3b | 30–44 | Moderately to severely decreased |
| G4 | 15–29 | Severely decreased |
| G5 | Below 15 | Kidney failure range; treatment planning depends on the full clinical picture |
These categories help organize care, but they are not a diagnosis by themselves. Results should be interpreted alongside age, symptoms, blood pressure, diabetes status, medicines, urine findings, and the direction of change over time.
How to compare options
The most useful comparison is usually not between one laboratory result and a universal “normal” value. Compare the same person’s results over time, using the same units and considering the circumstances of each test. Ask whether the eGFR is stable, slowly changing, or falling quickly; whether urine albumin is present; and whether a recent illness or medication change could explain a short-term difference.
Urine albumin-to-creatinine ratio (UACR) adds information that eGFR cannot provide. Albumin is a protein that may appear in urine when the kidney’s filtering barrier is affected. UACR is commonly grouped as follows:
| Albuminuria category | UACR | General interpretation |
|---|---|---|
| A1 | Less than 30 mg/g | Normal to mildly increased |
| A2 | 30–300 mg/g | Moderately increased |
| A3 | More than 300 mg/g | Severely increased |
Albumin in urine can vary. Exercise, fever, urinary infection, uncontrolled blood pressure, high blood glucose, and menstruation may affect a sample. An unexpectedly high result is often repeated or confirmed under more representative conditions. A clinician may also review a routine urinalysis, electrolytes, blood pressure, and prior results.
Feature-by-feature breakdown
Trend versus single result
A trend is generally more informative than an isolated eGFR. Small changes may reflect normal laboratory or biological variation. A larger or persistent change deserves review, especially if it occurs with swelling, reduced urine output, blood in the urine, breathlessness, vomiting, severe weakness, or confusion. Do not wait for a routine appointment if symptoms are severe or rapidly worsening.
Temporary causes of a lower eGFR
Dehydration, acute infection, vomiting or diarrhea, recent surgery, urinary blockage, and some medicines can temporarily affect creatinine or kidney function. A clinician may ask about nonprescription pain relievers, supplements, recent contrast imaging, and changes in prescription medicines. Do not stop a prescribed medicine without advice; instead, provide a complete medication list and explain when the change began. A medication-reconciliation checklist can help organize this information.
Confirmatory testing
When creatinine-based eGFR may be less reliable, clinicians may repeat the test or use another marker, such as cystatin C, when available and appropriate. This can be useful when a treatment decision depends on a borderline result or when muscle mass, diet, amputation, or another factor makes creatinine harder to interpret. The choice of test depends on the clinical question and local laboratory practice.
Medicines and contrast precautions
Kidney function can affect the dose or safety monitoring of several medicines. Bring recent kidney results to visits involving new prescriptions, procedures, or dose changes. Before an imaging study involving contrast, tell the imaging team about CKD, a previous kidney injury, diabetes, dehydration, and all medicines. The team can decide whether additional precautions or a different test is appropriate; patients should not cancel necessary imaging based on an eGFR number alone.
Best fit by scenario
- One unexpectedly low eGFR: Ask whether you were ill or dehydrated, whether the result should be repeated, and what prior results show.
- Diabetes or high blood pressure: Ask how often eGFR and UACR should be checked and what blood pressure or glucose targets apply to you.
- Persistently reduced eGFR or increased UACR: Ask about the likely cause, kidney-protective treatment, medicine dosing, monitoring intervals, and whether kidney-specialist input is appropriate.
- Rapid change or concerning symptoms: Contact a clinician promptly. Reduced urine, new swelling, severe breathlessness, confusion, chest pain, or inability to keep fluids down may require urgent assessment.
- Before a medicine or procedure: Share your latest results and medication list, including over-the-counter pain medicines and supplements.
For your records, note the test date, eGFR, creatinine, UACR, blood pressure, recent illness, hydration status, and medication changes. This simple log can make comparisons more meaningful and help identify questions that need follow-up.
When to revisit
Return to this guide after every kidney-function test, after a medication change, during or shortly after an acute illness, or when a new diagnosis such as diabetes or hypertension is made. Also revisit it before contrast imaging, surgery, or a consultation about a new treatment. The appropriate testing interval varies with kidney function, albuminuria, the cause of kidney disease, age, comorbidities, and the stability of previous results; your clinician should set the schedule rather than relying on a general calendar.
At each review, compare the newest eGFR and UACR with earlier values, ask whether the change is clinically meaningful, and confirm the next step. CKD staging systems, laboratory reporting conventions, medication guidance, and referral recommendations can change as clinical guidance is updated, so this article should be reviewed periodically. It is an educational resource, not a diagnosis or substitute for individualized medical advice.